Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma.

Saved in:
Bibliographic Details
Title: Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma.
Authors: Lee PH; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.; Rong Hsing Research Center For Translational Medicine, National Chung Hsing University, Taichung, Taiwan., Chiang CJ; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.; Taiwan Cancer Registry, Taipei, Taiwan., Tseng JS; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan., Zheng ZR; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan., Chen KC; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan., Chu CH; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan., Huang YH; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan., Hsu KH; Division of Critical Care and Respiratory Therapy, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan., Lee WC; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.; Taiwan Cancer Registry, Taipei, Taiwan., Yang TY; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan., Liu TW; National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan., Hsia JY; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Division of Thoracic Surgery, Department of Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan., Chang GC; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Source: Frontiers in oncology [Front Oncol] 2023 Feb 28; Vol. 13, pp. 1096683. Date of Electronic Publication: 2023 Feb 28 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2023.1096683